{"disease":{"id":"acute-rejection-of-renal-transplant","name":"acute rejection of renal transplant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05084768","title":"Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Loma Linda University","has_results":false},{"nct_id":"NCT06476717","title":"Donor-derived Cell-free DNA in Kidney Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT01544491","title":"Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04665310","title":"Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":46,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false},{"nct_id":"NCT05799716","title":"Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT03317925","title":"Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}